Anti-cancer drug benefits women with breast cancer who have failed previous treatments
Friday, September 27, 2013 - 22:30
in Health & Medicine
First results from a phase III clinical trial of the combination drug, T-DM1, show that it significantly improves the length of time before breast cancer worsens in women with advanced HER2 positive breast cancer whose cancer has recurred or progressed despite previous treatments, including trastuzumab and lapatinib.